Rankings
▼
Calendar
IART FY 2023 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena
IART
Integra LifeSciences Holdings Corporation
$738M
FY 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$1.5B
-1.0% YoY
Gross Profit
$885M
57.4% margin
Operating Income
$112M
7.2% margin
Net Income
$68M
4.4% margin
EPS (Diluted)
$0.84
Cash Flow
Operating Cash Flow
$140M
Free Cash Flow
$73M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$3.8B
Total Liabilities
$2.2B
Stockholders' Equity
$1.6B
Cash & Equivalents
$276M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.5B
$1.6B
-1.0%
Gross Profit
$885M
$970M
-8.8%
Operating Income
$112M
$239M
-53.3%
Net Income
$68M
$181M
-62.5%
← Q4 2022
All Quarters
Q1 2023 →